INZY
Price
$3.43
Change
-$0.12 (-3.38%)
Updated
Nov 14 closing price
125 days until earnings call
MIST
Price
$1.81
Change
-$0.03 (-1.63%)
Updated
Nov 14 closing price
137 days until earnings call
Ad is loading...

INZY vs MIST

Header iconINZY vs MIST Comparison
Open Charts INZY vs MISTBanner chart's image
Inozyme Pharma
Price$3.43
Change-$0.12 (-3.38%)
Volume$321.54K
CapitalizationN/A
Milestone Pharmaceuticals
Price$1.81
Change-$0.03 (-1.63%)
Volume$231.06K
CapitalizationN/A
INZY vs MIST Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. MIST commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a StrongBuy and MIST is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (INZY: $3.43 vs. MIST: $1.81)
Brand notoriety: INZY and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 129% vs. MIST: 84%
Market capitalization -- INZY: $220.34M vs. MIST: $96.42M
INZY [@Biotechnology] is valued at $220.34M. MIST’s [@Biotechnology] market capitalization is $96.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, MIST is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 3 TA indicator(s) are bullish while MIST’s TA Score has 5 bullish TA indicator(s).

  • INZY’s TA Score: 3 bullish, 7 bearish.
  • MIST’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MIST is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -16.34% price change this week, while MIST (@Biotechnology) price change was -7.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

MIST is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($220M) has a higher market cap than MIST($96.4M). MIST YTD gains are higher at: 8.383 vs. INZY (-19.484).
INZYMISTINZY / MIST
Capitalization220M96.4M228%
EBITDAN/AN/A-
Gain YTD-19.4848.383-232%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
INZYMIST
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.38%
BEAM - INZY
57%
Loosely correlated
-4.33%
FATE - INZY
54%
Loosely correlated
-4.15%
DNLI - INZY
50%
Loosely correlated
-3.98%
NTLA - INZY
49%
Loosely correlated
-6.15%
PLRX - INZY
49%
Loosely correlated
-6.68%
More

MIST and

Correlation & Price change

A.I.dvisor tells us that MIST and JBPHF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and JBPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-1.63%
JBPHF - MIST
31%
Poorly correlated
N/A
VERV - MIST
26%
Poorly correlated
-7.08%
KRYS - MIST
25%
Poorly correlated
-3.71%
CLDX - MIST
25%
Poorly correlated
-4.10%
INZY - MIST
24%
Poorly correlated
-3.38%
More